Literature DB >> 7097409

Rubella immunity in older children, teenagers, and young adults: a comparison of immunity in those previously immunized with those unimmunized.

R G Robinson, F E Dudenhoeffer, H J Holroyd, L R Baker, D I Bernstein, J D Cherry.   

Abstract

Because rubella continues to be a common illness in adolescents and young adults and because it has been suggested that booster rubella immunizations should be performed, we studied antibody prevalence in 459 predominantly adolescent patients in a pediatric group practice. Rubella antibody (PHA titer greater than or equal to 1:13.5) in previously immunized patients (89.6% of 385) was significantly more common than antibody in unimmunized patients and patients with a questionable history of immunization (70.3% of 74) (P less than 0.005). Twenty-three seronegative patients with a documented history of prior immunization were reimmunized and 22 had an IgG (secondary) antibody response and only one an IgM (primary) antibody response. Since all but one of our patients with previous immunization had a secondary immune response following revaccination, it seems likely that the level of protection in previously vaccinated individuals is considerably greater than 90%. Attention today should be directed at finding and immunizing unvaccinated teenagers and young adults and not in major booster vaccine programs.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7097409     DOI: 10.1016/s0022-3476(82)80114-5

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  5 in total

1.  Identifying risk factors for rubella susceptibility in a population at risk in the United States.

Authors:  M Carolina Danovaro-Holliday; Ely R Gordon; Charles Woernle; Gary H Higginbotham; Randa H Judy; Joseph P Icenogle; Susan E Reef
Journal:  Am J Public Health       Date:  2003-02       Impact factor: 9.308

2.  Premarital screening for syphilis.

Authors:  J Goldenring
Journal:  West J Med       Date:  1985-01

3.  Rubella vaccination: a course becomes clear.

Authors:  J S Spika; D K Clogg
Journal:  Can Med Assoc J       Date:  1983-07-15       Impact factor: 8.262

4.  Rubella reimmunization: comparative analysis of the immunoglobulin G response to rubella virus vaccine in previously seronegative and seropositive individuals.

Authors:  L A Mitchell; M K Ho; J E Rogers; A J Tingle; R G Marusyk; J M Weber; P Duclos; M L Tepper; M Lacroix; M Zrein
Journal:  J Clin Microbiol       Date:  1996-09       Impact factor: 5.948

5.  How to determine protective immunity in the post-vaccine era.

Authors:  Carmen L Charlton; Florence Y Lai; Douglas C Dover
Journal:  Hum Vaccin Immunother       Date:  2016-04-02       Impact factor: 3.452

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.